BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19547629)

  • 1. Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention.
    Andreas S; Hering T; Mühlig S; Nowak D; Raupach T; Worth H
    Dtsch Arztebl Int; 2009 Apr; 106(16):276-82. PubMed ID: 19547629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guidelines for smoking cessation in patients with COPD issued by the Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin].
    Andreas S; Batra A; Behr J; Berck H; Chenot JF; Gillissen A; Hering T; Herth F; Meierjürgen R; Mühlig S; Nowak D; Pfeifer M; Raupach T; Schultz K; Sitter H; Worth H;
    Pneumologie; 2008 May; 62(5):255-72. PubMed ID: 18461537
    [No Abstract]   [Full Text] [Related]  

  • 3. Smoking Cessation in Chronic Obstructive Pulmonary Disease.
    Tashkin DP
    Semin Respir Crit Care Med; 2015 Aug; 36(4):491-507. PubMed ID: 26238637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Smoking cessation in smokers with chronic obstructive pulmonary disease].
    Underner M; Perriot J; Peiffer G
    Rev Mal Respir; 2014 Dec; 31(10):937-60. PubMed ID: 25496790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial.
    Ellerbeck EF; Nollen N; Hutcheson TD; Phadnis M; Fitzgerald SA; Vacek J; Sharpe MR; Salzman GA; Richter KP
    JAMA Netw Open; 2018 Sep; 1(5):e181843. PubMed ID: 30646142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
    Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
    Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.
    Laniado-Laborín R
    Int J Environ Res Public Health; 2009 Jan; 6(1):209-24. PubMed ID: 19440278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Smoking cessation in patients with COPD].
    Andreas S; Batra A; Behr J; Chenot JF; Gillissen A; Hering T; Herth FJ; Kreuter M; Meierjürgen R; Mühlig S; Nowak D; Pfeifer M; Raupach T; Schultz K; Sitter H; Walther JW; Worth H
    Pneumologie; 2014 Apr; 68(4):237-58. PubMed ID: 24570269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do we need tailored smoking cessation interventions for smokers with COPD? A comparative study of smokers with and without COPD regarding factors associated with tobacco smoking.
    van Eerd EA; van Rossem CR; Spigt MG; Wesseling G; van Schayck OC; Kotz D
    Respiration; 2015; 90(3):211-9. PubMed ID: 26022403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-care Provider Screening and Advice for Smoking Cessation Among Smokers With and Without COPD: 2009-2010 National Adult Tobacco Survey.
    Schauer GL; Wheaton AG; Malarcher AM; Croft JB
    Chest; 2016 Mar; 149(3):676-84. PubMed ID: 26291388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.
    Wagena EJ; Zeegers MP; van Schayck CP; Wouters EF
    Drug Saf; 2003; 26(6):381-403. PubMed ID: 12688831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Epidemiological Case-Control Study of Pharmacological Smoking Cessation Treatment in Danish Patients with Chronic Obstructive Pulmonary Disease.
    Andelius DK; Hilberg O; Ibsen R; Løkke A
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2433-2443. PubMed ID: 34465989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronic Cigarette Use in US Adults at Risk for or with COPD: Analysis from Two Observational Cohorts.
    Bowler RP; Hansel NN; Jacobson S; Graham Barr R; Make BJ; Han MK; O'Neal WK; Oelsner EC; Casaburi R; Barjaktarevic I; Cooper C; Foreman M; Wise RA; DeMeo DL; Silverman EK; Bailey W; Harrington KF; Woodruff PG; Drummond MB;
    J Gen Intern Med; 2017 Dec; 32(12):1315-1322. PubMed ID: 28884423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and Facilitators for Smoking Cessation in Chinese Smokers with Chronic Obstructive Pulmonary Disease: A Qualitative Study.
    Zhang YY; Tang WT; Zhang H; Wang J; Bai XX; Liao YH; Robinson N; Liu JP
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1107-1120. PubMed ID: 35573655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of theory-based smoking cessation interventions in patients with chronic obstructive pulmonary disease: a meta-analysis.
    Han M; Fu Y; Ji Q; Deng X; Fang X
    BMC Public Health; 2023 Aug; 23(1):1510. PubMed ID: 37559043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease.
    O'Donnell DE; Aaron S; Bourbeau J; Hernandez P; Marciniuk D; Balter M; Ford G; Gervais A; Goldstein R; Hodder R; Maltais F; Road J; McKay V; Schenkel J; Ariel A; Day A; Lacasse Y; Levy R; Lien D; Miller J; Rocker G; Sinuff T; Stewart P; Voduc N; Abboud R; Ariel A; Becklake M; Borycki E; Brooks D; Bryan S; Calcutt L; Chapman K; Choudry N; Couet A; Coyle S; Craig A; Crawford I; Dean M; Grossman R; Haffner J; Heyland D; Hogg D; Holroyde M; Kaplan A; Kayser J; Lein D; Lowry J; McDonald L; MacFarlane A; McIvor A; Rea J; Reid D; Rouleau M; Samis L; Sin D; Vandemheen K; Wedzicha JA; Weiss K;
    Can Respir J; 2004; 11 Suppl B():7B-59B. PubMed ID: 15340581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
    Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Trends in Smoking Cessation Medication Prescriptions for Smokers With Chronic Obstructive Pulmonary Disease in the United States, 2007-2012.
    Kwak MJ; Kim J; Bhise V; Chung TH; Petitto GS
    J Prev Med Public Health; 2018 Sep; 51(5):257-262. PubMed ID: 30286598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD.
    Melzer AC; Feemster LC; Collins MP; Au DH
    J Hosp Med; 2016 Apr; 11(4):257-63. PubMed ID: 26663891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.